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WELCOME ADDRESS 
 
Dear Colleagues and Friends, 
 
It is our pleasure to welcome you to Groningen to attend the 19th European Symposium on 
Radiopharmacy and Radiopharmaceuticals in April 2018. 
 
Groningen, an old Hanseatic city with 180.000 inhabitants including 40.000 students, has an old University 
from 1614, a University Medical Center of 1300 beds and a referral base of 2.5 Million inhabitants from 
the Northern provinces in the Netherlands. As a result, Groningen is a very cozy city with many hotels, 
bars and restaurants and almost everything is within walking distance. The MartiniPlaza venue is located 
at about 20 min walking from the city center and the railway station and is very conveniently located for 
arrivals by car. Groningen can be easily reached by car and train. For those who travel by plane, the closest 
airport is Amsterdam Schiphol connecting to Groningen with trains leaving every 30 min. The train ride 
takes 2 hours. 
 
The Department of Nuclear Medicine and Molecular Imaging in Groningen has a longstanding tradition 
(>40 years) in the development and production of radiopharmaceuticals and is very active within different 
activities in the Netherlands and the EANM with respect to radiopharmaceuticals. 
 
The current infrastructure includes an IBA C18 cyclotron, a fully equipped GMP-PET laboratory including 
17 hot cells and GMP-SPECT cleanrooms also including a facility for 89Zr-labelling. 
 
Therefore, Groningen is the ideal location to host an attractive and innovative Radiopharmacy meeting 
covering all scientific and regulation aspects. We are looking forward to host you and set the scene for 
fruitful meetings and discussions. 
 
Welcome to Groningen! 
 
Philip Elsinga 
Erik de Vries 
Gert Luurtsema 
Hendrikus Boersma 
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SCIENTIFIC COMMITTEE 
Philip Elsinga  Netherlands 
Antony Gee  United Kingdom 
Petra Kolenc-Peitl  Slovenia 
Peter Laverman  Netherlands 
Tom Mindt Austria  
 
LOCAL ORGANISING COMMITTEE 
Philip Elsinga   
Erik de Vries   
Gert Luurtsema   
Hendrikus Boersma 
 
ORGANISING SECRETARIAT 
EANM Executive Secretariat 
Andreas Felser 
Petra Neubauer 
Schmalzhofgasse 26 
1060 Vienna, AUSTRIA 
Tel.:  +43-(0)1 890 44 27 
Fax:  +43-(0)1 890 44 27 - 9 
Email:  office@esrr.info 
URL:  www.esrr.info 
 
CONGRESS VENUE 
MartiniPlaza 
L. Springerlaan 2 
9702 KA Groningen, NETHERLANDS  
Tel.: +31 (0)50 5222 621 
URL: https://www.martiniplaza.nl/ 
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EXHIBITORS & SPONSORS  
We would like to thank all exhibitors and sponsor of the ESRR 2018 for their support! 
 
ABX advanced biochemical compounds 
ABX-CRO advanced pharmaceutical services 
COMECER S.p.A. 
Elysia-raytest 
GE Healthcare   
IBA SA (ION BEAM APPLICATION) 
IDB Holland BV 
iPHASE 
IRE ELIT 
ITM Isotopen Technologien München AG  
LabLogic Systems Limited 
MILabs b.v. 
Molecubes 
NRG 
ORA-NEPTIS 
Rotem GmbH 
ROTOP 
Scintomics GmbH 
Trasis SA 
Von Gahlen Nederland B.V.  
  
 Making Molecular Imaging Clear
ABX
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GENERAL INFORMATION (A-Z) 
 
Bicycle Rental  
There are various locations in Groningen for hiring a bicycle. OV bicycles are available for hire at 
the Groningen main railway station, Winschoten station and the Euroborg P+R (P3). The province 
has numerous wonderful options for cycling, such as routes through the Westerkwartier or along 
the Lauwersmeer Lake. Enjoying the Oldambt and expansive skies of the highland is even better 
from your bike. Peddel & Pedaal is a very special way to explore Westerwolde, with various 
bicycle routes combined with a canoe trip. 
 
Certificate of Attendance 
Upon arrival all registered delegates will receive a certificate of attendance. 
 
Climate 
The daytime temperatures in April linger between 3° - 13° Celsius.  
 
Credit cards 
All major credit cards, including Eurocard, Diners, VISA and Mastercard are accepted in 
restaurants, hotels, shopping centers and stores.  
 
Currency 
The official currency in in the Netherlands is EUR (€). You can exchange your currency without 
any limits for total amount at all banks and exchange offices in Groningen. When exchanging your 
currency, you will need your passport or official ID-card. If you do not have it with you, the bank 
may refuse to exchange your currency 
 
Electricity 
The power supply in the Netherlands is 220/240 Volt-current. Most electric outlets adhere to the 
continental standard (Schuko). Appliances from North America require a transformer and British 
appliances require an adaptor for the two-pin sockets in use in the Netherlands. 
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Museums 
The Groningen Museum, a work of art in itself, is one of the most beautiful and special museums 
in the Netherlands. There are various museums in the city and province that highlight all of the 
aspects of Groningen, for example the Stripmuseum (Comic Strip Museum), or the Grafisch 
(Graphic) Museum. An art-loving city such as Groningen naturally has many galleries with 
regularly changing exhibitions all year round. 
 
Restaurants & Pubs 
Groningen has a variety of pubs and a number of restaurants which have been awarded a 
Michelin Star; all-night restaurants where the kitchens are open even after midnight, and in 
particular many pubs where your food is served. 
 
Secretariat & Registration desk 
The registration desk will be open: 
Thursday, April 05, 2018 17:00-20:00 
Friday, April 06, 2018  08:00-17:30 
Saturday, April 07, 2018 08:00-17:30 
Sunday, April 08, 2018 08:00-12:00 
 
Shopping 
From Tuesday till Friday most stores are opened from 10 AM until 6 PM. On Saturday you can 
shop until 5 PM. On Monday mornings, most shops in the city centre are closed until 1 PM (this 
does not apply to all companies). On weekdays, most shops are open until 6 PM. In Groningen 
you can shop seven days per week – Shops are now also opening their doors on Sunday. 
Groningen shops have late night shopping on Thursday evenings when many shops are open until 
9 pm.  
 
Taxes & Tipping 
The standard tax rate is 21%, however, some services such as hotel, food and transport have a 
reduced rate of 6%. Most services do not include tipping. In higher class restaurants it is common 
to give up to 10% of the total. For any other services (taxi, restaurants, hotel) it is up to you how 
much you want to give. 
 
Time zone 
Central European Time (CET) is 1 hour ahead of Coordinated Universal Time (UTC).  
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Delegate Registration Fees include: 
• Access to all scientific session  
• Access to poster exhibition 
• Access to industry exhibition 
• Free copy of all congress documentation 
• Certificate of attendance 
• Lunch- April 06 & 07, 2018 
• Coffee breaks April 06, 07 & 08, 2018 
• Invitation to the Opening Ceremony and Welcome Reception – April 05, 2018 
• Invitation to the Closing Ceremony – April 08, 2018 
• Conference Dinner – April 06, 2018 
• Social Dinner – April 07, 2018 
 
Accompanying Person Registration Fees include:  
• Invitation to the Opening Ceremony and Welcome Reception – April 05, 2018 
• Invitation to the Closing Ceremony – April 08, 2018 
• Conference Dinner – April 06, 2018 
• Social Dinner – April 07, 2018 
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PROGRAMME OVERVIEW 
 
THURSDAY, APRIL 05, 2018 
19:30-19:50  Opening Ceremony & Welcome Meeting  
19:50-20:25  Welcome Lecture – Life: How did it originate and can we synthesize it? 
20:30-22:00  Welcome Reception  
 
FRIDAY, APRIL 06, 2018 
08:30-10:05  Session I – Radiometals and Arthropods 
10:05-10:35  Poster Viewing Session  
Coffee Break 
10:35-12:35  Session II – Radiolabelling Smorgasbord 
12:35-14:05  Lunch Break 
14:05-15:40  Session III – In Vivo Targetry 
15:40–16:30  Poster Viewing Session  
Coffee Break 
16:30-17:30  Session IV – Kill the Disease, not the Patient 
 
SATURDAY, APRIL 07, 2018 
08:30-10:15  Session V – In Vivo Archery 
10:15-11:00  Poster Viewing Session 
   Coffee Break 
11:00-12:45  Session VI – Malignant Malady Imaging 
12:45-14:15  Lunch Break 
14:15-15:50  Session VII – Seek and Destroy 
15:50-16:30  Poster Viewing Session 
Coffee Break 
16:30-17:30  Session VIII – The Art of the Drug Makers 
 
SUNDAY, APRIL 08, 2018 
08:30-10:30  Session IX – Product Scrutiny 
10:30-11:00  Poster Viewing Session 
Coffee Break 
11:00-12:35  Session X – Seek and Destroy Revisited  
12:35-13:15  Highlights/Closing 
13:15   Farewell Lunch 
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HIGHLIGHTS 
Invited Lectures 
 
Life: How did it originate and can we synthesize it? S. Otto, Netherlands 
Lecture 1: Cyclotron produced radiometals F. Alves, Portugal 
Lecture 2: In vivo Click Chemistry R. Rossin, Netherlands 
Lecture 3: Basics in kinetic modelling S. Krämer, Switzerland 
Lecture 4: Safety assessment requirements for radiopharmaceuticals 
                   for first in human studies (Toxicity and allometric upscaling) M. Behe, Switzerland 
Lecture 5: Transfer of preclinical dosimetry to humans M. Bardies, France 
Lecture 6: Neuroimaging I. Law, Denmark 
Lecture 7: Prostate cancer imaging: choline, PSMA, GRPR F. Verzijlbergen, Netherlands 
Lecture 8: Debate/Discussion - 68Ga-, 18F- or 99mTc-PSMA A. Windhorst, Netherlands 
 S. Terry, United Kingdom 
 M. de Jong, Netherlands 
Lecture 9: Immunocheckpoints A. Awada, Belgium 
European Pharmacopoeia: It is about Quality E. Pel, France 
New monographs and other ongoing projects T. Kroon, The Netherlands 
Lecture 10: Preparation from generators, kits and cyclotron  
                     produced nuclides - regulatory consequences R. Schulze, Germany 
Lecture 11: Changes in radiotracer production from the beginning  
                     to beyond 2020 – did we get better? P. Elsinga, Netherlands 
Lecture 12: True whole body dynamic PET - opportunities and challenges T. Jones, United Kingdom 
Lecture 13: Do we need radiochemists in the future? D. Vugts, Netherlands 
 
Invited Lectures are marked within the scientific programme in light blue.  
 
 
Social Programme 
Thursday, April 05, 2018 
20:30  Welcome Reception (Congress Venue) 
 
Friday, April 06, 2018  
19:00 Conference Dinner at MartiniPlaza 
 
Saturday, April 07, 2018 
18:30  Meeting Point at MartiniPlaza for the busses 
19:00  Social dinner at de Rietschans 
 
Sunday, April 09, 2018  
13:25  Farewell Lunch (Congress Venue) 
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SCIENTIFIC PROGRAMME 
Thursday, April 05, 2018 
19:30  Opening Ceremony & Welcome Meeting P. Elsinga, Netherlands / M. Patt, Germany 
19:50 Life: How did it originate and can we synthesize it? S. Otto, Netherlands 
 
20:30  Welcome Reception   
 
Friday, April 06, 2018 
08:30 Session I – Radiometals and Arthopods T. Mindt, Austria / M. Figols de Borboza, Brazil 
08:30 Lecture 1: Cyclotron produced radiometals F. Alves, Portugal 
09:15 OP01 Novel Acyclic Chelators for 89Zr and B. Guérin, Canada 
09:27 OP02 - Improving pretargeting by applying multimerisation on a cyclic chelating scaffold D. Summer, Austria 
09:39 OP03 99mTc-radiolabeling of a poorly soluble protein, a variable heavy  
   chain antibody domain targetingpancreatic b-cells M. Ahmadi, France 
09:51 OP04 -  Synthesis of PET radiopharmaceuticals for cell radiolabelling using  
  anion exchange column and cell labelling A. Socan, Slovenia 
10:05 Coffee Break & Poster Viewing Session  
 
10:35 Session II – Radiolabelling Smorgasbord E. de Vries, Netherlands / K. Kopka, Germany 
10:35 Lecture 2: In vivo Click Chemistry R. Rossin, Netherlands 
11:20 OP05 - Synthesis of 18F-AmBF3-losartan and preliminary in vitro  
  evaluation as a novel AT1R PET radioligand in Oncology M. Sahylí Ortega Pijeira, Brazil 
11:32 OP06 - Time is Money and Radiation Burden - a carbon-11  
  ‘two-in-one-pot’ production system C. Philippe, Austria 
11:44 OP07 - 18F-labelled BODIPY-steroid hormone conjugates as potential  
  bimodal PET and fluorescence receptor imaging agents J. van Lier, Canada 
11:56 OP08 - Copper-mediated radiofluorination of aryl pinacol boronates 
  in the presence of pyridinium sulfonates D. Antuganov, Russia 
12:08 OP09 - Development of biocompatible and functionalised polymer 
  nanoparticles for the specific vectorisation of an imaging agent N. Lepareur, France 
12:20 OP10 - Development of a new generation propylene cross-bridged chelator 
  as versatile platform for antibody radiolabeling with Cu-64 S. Sarkar, South Korea 
12:35 Lunch Break  
 
14:05 Session III – In Vivo Targetry P. Laverman, Netherlands / S. Krämer, Switzerland 
14:15 Lecture 3: Basics in kinetic modelling S. Krämer, Switzerland 
14:50 OP11 - Pseudomonas aeruginosa infection imaging with 
  Ga-68 labelled pyoverdine M. Petrik, Czech Republic 
15:02 OP12 - Modifying the siderophore triacetylfusarinine C  
  for molecular imaging applications K. Kaeopookum, Austria 
15:14 OP13 - In vitro and in vivo comparison of the novel 89Zr  
  chelator DFO-cyclo* with DFO R. Raavé, Netherlands 
15:26 OP14 - Characterization by Radio-HPLCS of Cell Effluxes and  
  Cell Extracts of 99mTc-HMPAO Human Leukocytes T. Martinez, Spain 
15:40 Meet the Author Poster Viewing Session 
 
16:30 Session IV – Kill the Disease, not the Patient M. Behe, Switzerland / A. Windhorst, Netherlands 
16:30 Lecture 4: Safety assessment requirements for radiopharmaceuticals  
        for first in human studies (Toxicity and allometric upscaling) M. Behe, Switzerland 
17:00 Lecture 5: Transfer of preclinical dosimetry to humans M. Bardies, France 
17:30  Round Table/Discussion 
ESRR’18 – 19th European Symposium on 
Radiopharmacy & Radiopharmaceuticals 
Thursday, April 5 – Sunday, April 8, 2018  
MartiniPlaza, Groningen, NETHERLANDS 
 
 
Page 10 
Saturday, April 07, 2018 
08:30 Session V – In Vivo Archery G. Luurtsema, Netherlands / R. Krasikova, Russia 
08:30 Lecture 6: Neuroimaging  I. Law, Denmark 
09:15 OP15 - In vivo imaging of mGluR1 neuroreceptor kinetics in mouse brain  
  with [11C]ITDM microPET S. Korat, Belgium 
09:27 OP16 - Anesthesia affects P-glycoprotein function at the Blood-Brain Barrier:  
  A PET study with [18F] MC225 in rats L. Garcia Varela, Groningen 
09:39 OP17 – An 18F-labeled derivative of baclofen for imaging  
  GABAB receptors in mouse brain A. Horti, United States 
09:51 OP18 - Measurement of blood brain barrier transport using radiolabeled antibodies G. Charest, Canada 
10:03 OP19 - Synthesis and 18F-Radiolabelling of Novel Benzoimidazotriazines 
  for Imaging of Phosphodiesterase 2A (PDE2A) R. Ritawidya, Germany 
10:15 Meet the Author Poster Viewing Session 
 
10:45 Session VI – Malignant Malady Imaging P. Kolenc Peitl, Slovenia / A. Rey, Uruguay 
10:45 Lecture 7: Prostate cancer imaging: choline, PSMA, GRPR F. Verzijlbergen, Netherlands 
11:30 Lecture 8: Debate/Discussion - 68Ga-, 18F- or 99mTc-PSMA 
         S. Terry (Ga-68), A. Windhorst (F-18), M. de Jong (Tc-99m)  
11:42 OP20 - 64Cu-labelled anti-miRNA peptide nucleic acids as probes for  
  molecular imaging of miRNA expression M. Asti, Italy 
11:54 OP21 - Correlation between 89Zr-DFO-Trastuzumab-DM1 Delivery  
  versus the Cytotoxicity and Response of T-DM1 on HER2  
  Expressing Breast Cancer Xenografts N. Alsaden, Toronto 
12:06 OP22 - Physicochemical and in vitro evaluation of a 99mTc labelled  
  NPY1 short analogue as potential breast cancer imaging agent A. Rey, Uruguay 
12:45 Lunch Break 
 
14:15 Session VII – Seek and Destroy S. Todde, Italy / H. Audrain, Denmark 
14:15 Lecture 9: Immunocheckpoints A. Awada, Belgium 
15:00 OP23 - 177Lu-DOTA-MGS5: the long-awaited theranostic probe for  
  targeting cholecystokinin-2 receptor expression in medullary  
  thyroid carcinoma and other tumours M. Klingler, Austria 
15:12 OP24 - In vivo evaluation of biocompatible 99mTc-bisphosphonate-coated  
  MNPs designed as potential theranostic agents M. Mirkovic, Serbia 
15:24 OP25 - In vitro therapeutic efficacy of 67Ga-trastuzumab S. Terry, United Kingdom 
15:36 OP26 - 90Y-labeled phosphate-coated magnetic nanoparticles  
  designed for possible medical applications M. Radovic, Serbia 
15:50 Coffee Break & Poster Viewing Session 
 
16:30 Session VIII – The Art of the Drug Makers C. Decristoforo, Austria / E. Janevik, Republic of Macedonia 
  European Pharmacopoeia: It is about Quality E. Pel, France 
  New monographs and other ongoing projects T. Kroon, The Netherlands 
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Sunday, April 08, 2018 
08:30 Session IX – Product Scrutiny H. Boersma, Netherlands / J. Aerts, Luxembourg 
08:30 Lecture 10: Preparation from generators, kits and cyclotron produced nuclides  
           - regulatory consequences R. Schulze, Germany 
09:00 OP27 - Automation of FDG QC on Tracer-QC system A. Elizarov, Unites States 
09:12 OP28 - Simultaneous determination of the potentially toxic chemical  
  impurities in the radiopharmaceuticals by capillary electrophoresis D. Antuganov, Russia 
09.24 OP29 - Evaluation of factors influencing the Ga-68 yield and Ge-68  
  breakthrough of a SnO2 based Gallium-68 generator S. Rubow, South Africa 
09:36 OP30 - iTLC Method for Analysis of 68Ga Radiophamaceuticals A. Larenkov, Russia 
09:48 OP31 - Optimizatzion of [18F]-FPSMA1007 Synthesis HPLC free on Fastlab platform E. Cazzola, Italy 
10:00 Lecture 11: Changes in radiotracer production from the beginning to  
           beyond 2020 – did we get better? P. Elsinga, Netherlands 
10:30 Coffee Break & Poster Viewing Session 
 
11:00 Session X – Seek and Destroy Revisited M. Patt, Switzerland / S. Rubow, South Africa 
11:00 Lecture 12: True whole body dynamic PET - opportunities and challenges T. Jones, United Kingdom 
11:30 Lecture 13: Do we need radiochemists in the future? D. Vugts, Netherlands 
12:00 OP32 - Synthesis and evaluation of radioiodinated and astatinated prosthetic groups 
   for bioorthogonal conjugation to antibodies for nuclear imaging and therapy L. Navarro, France 
12:12 OP33 - Relative biological effectiveness (RBE) of 177lutetium-NOTA-panitumumab  
  F(ab')2 fragments for radioimmunotherapy of pancreatic cancer cell lines A. Boyle, Canada 
12:24 OP34 - Biological Assessment of a Radiolabelled LXXLL-Peptide for  
  Breast Cancer Theranostics   L. Gano, Portugal 
 
 
12:35 Highlights / Closing  P. Laverman, Netherlands 
 
13:15 Farewell Lunch  
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POSTER PRESENTATIONS 
 
PP01:  Optimization of Biological Quality Control of Radiochemical Precursors used for Radiopharmaceuticals 
Formulations – A step towards Good Radiopharmacy Practice   
A. Mitrai, India 
PP02: Production of 64Cu using indigenously developed solid target assembly in Medical Cyclotron Facility in 
Radiation Medicine Centre 
K. Kushwaha, India 
PP03: Microfluidic reactor in a PDMS chip for [18F]F-radiopharmaceuticals  
L. Fernandez Maza, Spain 
PP04: Development and comparison of dual generator elution methods on a MultiSyn Synthesizer (iPHASE 
technologies Pty Ltd) - application to the synthesis of 68Ga-peptides. 
L. Morandeau, Australia  
PP05: Radiolabelling of DTPA-silk fibroin nanoparticles with 111In for nanoparticle  biodistribution studies 
T. Martinez Martinez, Spain 
PP06:  First approaches to radiolabelling of silk fibroin nanoparticles with 99mTc 
T. Martinez Martinez, Spain 
PP07: Investigation of radiopharmaceutical potential of a new radiolabeled graft polymer for using the 
therapy and in the molecular imaging on albino wistar rats 
B. Ates, Turkey 
PP08: Production of Lutetium-177 DOTATATE/PSMA-617 on a MultiSyn radio-synthesizer module for use in 
Molecular Radiotherapy 
A. Asad, Australia 
PP09: Production of norepinephrine transporter tracer, [18F]NS12137, via  copper-mediated nucleophilic 18F-
fluorination  
S. Lahdenpohja, Finland 
PP10:  Production, applications and status of zirconium-89 immunoPET Agents; an IAEA new Coordinated 
Research Project  
 A. Jalilian, Austria 
PP11: Assay of Bacterial Endotoxins in Radiopharmaceuticals by Microplate Reader  
H. Kvaternik, Austria  
PP12: Ga-68 labeled quinazoline monomers and dimers bearing the HBED-CC chelator as PET tracers for EGFR-
TK imaging 
C. Liolios, Germany 
PP13: Prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPr) PET-imaging 
for prostate and breast cancer; tumor models and interactions with clinical relevance  
C. Liolios, Germany 
PP14: Radiolabeling of single domain antibodies with Tc-99m: evaluation of the best parameters for 
complexation allowing to preserve 3D conformation 
S. Bacot, France 
PP15: A comparison of four different dose calibrators using various isotopes and sample geometries  
 I. Pooters, Netherlands 
PP16: A first synthesis of 11C-labelled analog of 4’-O-methylhonokiol as a potential  PET radiotracer for 
inflammation  
M. Kiseleva, Russia 
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PP17: Synthesis of WX-360-derived, uPAR-binding PET Tracers and Development of a Platform to Evaluate 
Their in Vitro Binding Affinities 
A. Wacker, Germany 
PP18: Fully-automated production of 2´-[18F]fluoroflumazenil without using gradient HPLC purification 
 F. Trejo-Ballado, Mexico 
PP19: Radioiodination of Small Molecules and Short Peptides; the Effect of Oxidant Reagents Choice on the 
Radiochemical Yields 
M. Al-Qahtani, Saudi Arabia 
PP20: The Use of Nano-Sized Particles in Labelling New Class of Radiopharmaceuticals 
M. Al-Qahtani, Saudi Arabia 
PP21: Biological Investigations of a laminin Class Peptide that has a potential as a Diagnostic and Therapeutic 
Properties  
M. Al-Qahtani, Saudi Arabia 
PP22: Improvement of iodide and iodate identification method in the radiochemical analysis of Iodine-131 
radiopharmaceutical  
N. Fukumori, Brazil 
PP23: Delivery of DTPA through liposomes as a good strategy  
M. Mougin-Degraef, France 
PP24: Validation of a clean room for the production of radiopharmaceuticals at Turku PET Centre 
S. Forsback, Finland 
PP25: Use of gravity perfusion method in PRRT: Experimental evaluation and optimization 
 M. Ben Reguiga, France 
PP26: Interaction of 177LU-DOTATATE with pharmaceutical vehicles and peptides 
M. Ben Reguiga, France 
PP27:  Physiological 89Zr-Oxalate Solution for PET Diagnosis: Purification, Formulation, Biological Evaluation  
A. Larenkov, Russia 
PP28: Investigation of elution of the SnO2-based 68Ge/68Ga generator with different hydrochloric acid 
concentrations  
 S. Rubow, South Africa 
PP29: Radiolabeling Efficiency of Peptides that Interact with Overexpressed Receptors on Tumor Cells. 
Relevance to the Glioblastoma 
L. Malavolta, Brazil 
PP30: An automated synthesis of Ga-68 labelled ubiquicidine 
 S. Rubow, South Africa 
PP31: In vitro becteria-binding assays of radiolabeled Ampicillin loaded graphene oxide nanoflakes 
 F. Yurt, Turkey 
PP32: Room-temperature radiolabeling can be achieved by Al-18F chelation 
 R. Pal, Korea Republic (South) 
PP33: Pd catalyzed cross-coupling for 11C-PET tracer synthesis 
H. Helbert, Netherlands 
PP34: Effect of structural forms on the stability of linear and cyclic apoptosis-targeting peptides 
Y. Su Ha, Korea Republic (South) 
PP35: Synthesis and evaluation of a [18F]fluorinated quaternary α‑amino acid‑based arginase inhibitor 
G. Clemente, Netherlands 
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PP36: Facile synthesis of 6-L-[18F]fluoro-m-tyrosine via alcohol-enhanced  Cu-mediated radiofluorination of 
Bpin-substituted chiral Ni-BPB-AA complex 
R. Krasikova,Russia 
PP37: Physico-chemical assessment of labeled freeze dried kits of  trastuzumab-immunoconjugates significant 
for breast cancer therapy 
M. Sterjova, Republic of Macedonia 
PP38: Development of activity-based PET probes for selective detection of active caspase-3  
F. Elvas, Belgium 
PP39: Chemical analysis of cyclotron-based [68Ga]GaCl3 by ICP-MS 
K. Gagnon, Sweden 
PP40: Automation of Click Chemistry for the synthesis of 18F-labelled PSMA-tracers using the FlowSafe 
V. Böhmer, Netherlands 
PP41: [18F]-FEPPA, a 2nd generation of TSPO radioligand: optimized radiosynthesis and quality control 
N. Vignal, France 
PP42: Bioorthogonal chemistry applied to bispecific antibody manufacturing 
P. Le Saec, France 
PP43: A fast and robust quantification of residual solvents in radiopharmaceuticals by UHPLC 
 E. Da Costa, France 
PP44: Comparison between two octreotide derivatives for somatostatin receptor scintigraphy 
 A. Toumi, Tunisia 
PP45: Comparison of automated and manual labeling methods for somatostatin analogues with the example 
of DOTANOC and SomaKit TOC® 
A. Rauscher, France 
PP46: Optimization of automated 68Ga-PSMA-11 preparation by switch from tubing to GMP synthesizer 
L. Navarro, France 
PP47: Effective treatment of microscopic cancers with Tb-161 
Ø.A. Rusten, Norway 
PP48: Development of targeted radiopharmaceuticals with terbium-161 for use in radioimmunotherapy 
K. Eckell Skåre, Norway 
PP49: National regulations in Radiopharmacy: Is the present situation generally acceptable? 
E. Janevik-Ivanovska, Republic of Macedonia 
PP50: Optimization of production of [11C]CH3I with Methylator II  for synthesis and development of 11C 
radiopharmaceuticals  
E. Janevik-Ivanovska, Republic of Macedonia 
PP51: Formulation and Characterization Studies of Radiolabeled, Active Folate Targeted Theranostic Co-
Delivery Liposomes for Non-Small Cell Lung Cancer 
M. Karpuz-Oguz, Turkey 
PP52: HPLC method for analysis of DOTA-TOC 
 P. Garnuszek, Poland 
PP53:  Radiochemical purity determination of 68Ga-labelled radiopharmaceuticals.  
P. Garnuszek, Poland 
ESRR’18 – 19th European Symposium on 
Radiopharmacy & Radiopharmaceuticals 
Thursday, April 5 – Sunday, April 8, 2018  
MartiniPlaza, Groningen, NETHERLANDS 
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